When to Repeat Laboratory Tests Post-Transfusion
For red blood cell transfusions in stable patients, hemoglobin should be measured before and after every unit transfused, with post-transfusion testing performed as early as 15 minutes to 1 hour after completion, as equilibration occurs rapidly in normovolemic patients. 1
Red Blood Cell Transfusions
Timing of Post-Transfusion Testing
In hemodynamically stable, normovolemic patients without active bleeding, hemoglobin equilibration occurs within 15 minutes to 1 hour after transfusion. 2, 3 Research demonstrates that hemoglobin values measured at 15 minutes show excellent agreement with 24-hour values, with only 6% of patients exhibiting clinically significant differences (>6 g/L). 3
Laboratory measurement of hemoglobin remains the gold standard, though near-patient testing (blood gas analysis or HemoCue) correlates well and can be used for rapid assessment. 1
Single-unit transfusion strategy is recommended for stable patients, with careful monitoring and repeat measurement of post-transfusion hemoglobin to avoid overtransfusion and complications like transfusion-associated circulatory overload (TACO). 4
Important Caveats for RBC Testing
In actively bleeding patients, hemoglobin concentration may remain falsely elevated despite significant blood loss due to inadequate fluid resuscitation, making timing of repeat testing less reliable. 1
Hemoglobin concentration depends on both red cell mass and plasma volume; it may fall due to hemodilution from intravenous fluid administration even without ongoing blood loss. 1
Platelet Transfusions
Post-Transfusion Platelet Count Monitoring
Platelet counts should be obtained 10 to 60 minutes after transfusion completion whenever refractoriness is suspected. 5 The 10-minute timing is practical since the patient must be seen when the transfusion is completed to switch IV bags. 6
For patients undergoing invasive procedures, it is critical to determine the post-transfusion platelet count rather than assuming a hemostatic level has been achieved simply because a transfusion was administered. 5
A diagnosis of platelet refractoriness should only be made after at least two transfusions of ABO-compatible units stored for <72 hours result in poor increments (corrected count increment <5,000). 5
Post-transfusion counts should be obtained after all transfusions in non-bleeding hospitalized patients if day-to-day increments are not satisfactory, and after all transfusions to outpatients. 6
Monitoring During Transfusion
Vital Sign Assessment
Observations including pulse, blood pressure, temperature, and respiratory rate should be completed and documented before transfusion (within 60 minutes), 15 minutes after the start of each unit, and within 60 minutes of the end of transfusion. 7
Respiratory rate monitoring is essential throughout transfusion, as dyspnea and tachypnea are typical early symptoms of serious transfusion reactions. 7
Type and Screen Validity
A Type and Screen (T&S) is valid for up to three calendar days according to the American Association of Blood Banks. 8 Beyond this period, or in recently transfused patients, a new sample must be obtained within 3 days of scheduled transfusions. 9
Patients who develop unexpected alloantibodies after transfusion may have newly detectable antibodies within 83 hours of a previously negative sample, emphasizing the importance of adhering to the 3-day requirement. 9